Search results
This Drug Candidate Could Be a Winner for Bristol Myers
Motley Fool· 11 months agoLast month, Bristol Myers Squibb (NYSE: BMY) shared that its locally advanced or metastatic...
Bristol Myers to acquire brain drug developer Karuna for $14B
BioPharma Dive via Yahoo Finance· 4 months agoThe deal would hand Bristol Myers, which is reprioritizing neuroscience research, an experimental...
Bristol Myers says KRAS drug succeeds in key trial
BioPharma Dive via Yahoo Finance· 1 month agoConfirmatory results for Krazati, which Bristol Myers acquired via its buyout of Mirati, could help the drug win full approval while Amgen has been set...
US FDA approves Bristol-Myers' lung cancer drug
Reuters via Yahoo News· 6 months agoThe drug, to be sold under the brand name Augtyro, is set to compete in a crowded market for lung cancer treatments that includes Bristol Myers' other...
Bristol Myers wins dismissal of a $6.4 billion lawsuit over cancer drug delay
Reuters via Yahoo News· 1 year agoNEW YORK (Reuters) -A U.S. judge on Wednesday dismissed a lawsuit accusing Bristol Myers Squibb Co...
A Patent Cliff Is Coming For Bristol Myers — Can Billions In New Products Fill The Gap?
Investor's Business Daily· 1 year agoIt's a new day at Bristol Myers Squibb, according to a company executive. But BMY stock remains...
Bristol Myers pours $100M into RNA drugs for cardiovascular diseases
BioPharma Dive via Yahoo Finance· 5 months agoBristol Myers Squibb has agreed to spend at least $100 million to expand a partnership aimed at...
US FDA allows J&J, Bristol Myers cell therapies as early cancer treatments (April 5)
Reuters via AOL· 4 weeks agoThe U.S. Food and Drug Administration has allowed the cell therapies of Johnson & Johnson and...
FDA approves new Bristol Myers drug for lung cancer
BioPharma Dive via Yahoo Finance· 6 months agoAcquired via a $4 billion biotech buyout, Augtyro is one of an array of new products the pharma hopes will offset patent expirations for current top...
Bristol-Myers Squibb to acquire Mirati in up to $5.8 billion deal
Reuters via AOL· 7 months ago(Reuters) -Bristol-Myers Squibb on Sunday said it will acquire cancer drugmaker Mirati Therapeutics...